A. Morales

Technetium-99m-labeled anti-EGF-receptor antibody in patients with tumor of epithelial origin: I. Biodistribution and dosimetry for radioimmunotherapy.

A. Lage, M. Stabin, N. Iznaga-Escobar, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Freeze-dried formulation for direct 99mTc-labeling ior-egf/r3 MAb: additives, biodistribution, and stability.

N. Iznaga-Escobar, J. Duconge, A. Morales, 1999, Nuclear medicine and biology.

BIODISTRIBUTION AND DOSIMETRY OF 99 m Tc-LABELED MONOCLONAL ANTIBODY ior egf / r 3 IN PATIENTS WITH TUMORS OF EPITHELIAL ORIGIN : PRELIMINARY RESULTS

M. Stabin, N. Iznaga-Escobar, M. Ramos, 2022 .

Humanized versus murine anti-human epidermal growth factor receptor monoclonal antibodies for immunoscintigraphic studies.

N. Iznaga-Escobar, J. Duconge, A. Morales, 2000, Nuclear medicine and biology.

Technetium-99m direct radiolabeling of monoclonal antibody ior egf/r3.

A. Morales, N. Pérez, N. Iznaga Escobar, 1998, Nuclear medicine and biology.

Induction of neutralizing antibodies to transmissible gastroenteritis virus by anti-idiotypic antibodies.

F. Osorio, R. Moxley, S. Srikumaran, 1989, Viral immunology.

ior egf/r3: A murine monoclonal antibody for diagnostic of epithelial tumors

T. Rodríguez, M. R. Suzarte, A. Morales, 1999 .

99mTc-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: Part III. Clinical trials safety and diagnostic efficacy.

M. Ramos-Suzarte, N. Iznaga-Escobar, R. Pérez, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.